Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic Treatment”

Showing 20 of 0 results

Not applicableStudy completedNCT01029769
What this trial is testing

Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Technical University of Munich 350
Not applicableStudy completedNCT02600741
What this trial is testing

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

Who this might be right for
Schizophrenia
Janssen Scientific Affairs, LLC 296
Not applicableStudy completedNCT02712463
What this trial is testing

Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics

Who this might be right for
Schizophrenia
Janssen-Cilag Ltd. 310
Testing effectiveness (Phase 2)Ended earlyNCT00439634
What this trial is testing

Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia

Who this might be right for
Schizophrenia
Sanofi 873
Testing effectiveness (Phase 2)Study completedNCT03557931
What this trial is testing

Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication

Who this might be right for
Schizophrenia
Astellas Pharma Global Development, Inc. 233
Testing effectiveness (Phase 2)Study completedNCT02953639
What this trial is testing

Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics

Who this might be right for
Schizophrenia
Hoffmann-La Roche 214
Post-approval studies (Phase 4)Study completedNCT02305823
What this trial is testing

Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis

Who this might be right for
SchizophreniaPsychotic Disorders
Fundación Marques de Valdecilla 203
Not applicableStudy completedNCT02192723
What this trial is testing

Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia

Who this might be right for
Schizophrenia
Beijing HuiLongGuan Hospital 550
Post-approval studies (Phase 4)Study completedNCT00337662
What this trial is testing

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Eli Lilly and Company 628
Post-approval studies (Phase 4)Study completedNCT02435654
What this trial is testing

5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia

Who this might be right for
Early-onset Schizophrenia
Kunming Medical University 128
Post-approval studies (Phase 4)Study completedNCT00333177
What this trial is testing

Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia

Who this might be right for
Schizophrenia
University of California, Los Angeles 92
Not applicableUnknownNCT02880995
What this trial is testing

[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis

Who this might be right for
Schizophrenia
Seoul National University Hospital 62
Not applicableStudy completedNCT01491412
What this trial is testing

Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia

Who this might be right for
Acute Psychotic EpisodeSchizophrenia
AstraZeneca 503
Not applicableStudy completedNCT00169988
What this trial is testing

Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms

Who this might be right for
Prodromal SchizophreniaPsychotic Disorders
Northwell Health 8
Large-scale testing (Phase 3)Study completedNCT01448720
What this trial is testing

Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate

Who this might be right for
Schizophrenia
Janssen-Cilag Farmaceutica Ltda. 142
Testing effectiveness (Phase 2)Study completedNCT00215150
What this trial is testing

Geodon for the Treatment of Refractory Social Anxiety Disorder

Who this might be right for
Social Anxiety Disorder
Duke University 51
Post-approval studies (Phase 4)Study completedNCT00864825
What this trial is testing

Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sheba Medical Center 248
Post-approval studies (Phase 4)Study completedNCT02298985
What this trial is testing

Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients

Who this might be right for
Chronic Schizophrenia
Beersheva Mental Health Center 38
Post-approval studies (Phase 4)Study completedNCT02534363
What this trial is testing

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up

Who this might be right for
SchizophreniaPsychotic Disorders
Fundación Marques de Valdecilla 136
Not applicableStudy completedNCT03005769
What this trial is testing

Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Europe Ltd 262
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation